Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_provenance.
- NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_assertion description "[We demonstrate here that BGP-13, a new calcipotriene-based 1?,25-dihydroxyvitamin D3 analog that we synthesized in our laboratory, inhibits the growth of prostate cancer (LNCaP), breast cancer (MCF-7), and colon cancer (HT-29) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_provenance.
- NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_assertion evidence source_evidence_literature NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_provenance.
- NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_assertion SIO_000772 22661288 NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_provenance.
- NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_assertion wasDerivedFrom befree-20150227 NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_provenance.
- NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_assertion wasGeneratedBy ECO_0000203 NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP267292.RAcV_Uf7YlMtb4MKvAxrXJBTmUASghUjn_f1_OavC5HUk130_provenance.